GSK appoints new chief financial officer

GSK has announced that Julian Heslop will retire as chief financial officer at the end of March 2011 and will be replaced by Simon Dingemans

GlaxoSmithKline (GSK) has announced that Julian Heslop will retire from his role as chief financial officer (CFO) and executive director at the end of March 2011. He will be replaced by Simon Dingemans who will take up the roles of chief financial officer designate and executive director with effect from January 2011.

Simon Dingemans

Dingemans will join GSK from investment bank Goldman Sachs. During his 25 year career in investment banking, Dingemans has worked across multiple sectors including pharmaceuticals and consumer healthcare. Recently, he worked with GSK on their joint project with Pfizer to establish specialist HIV company ViiV Healthcare.

GSK CEO, Andrew Witty, said: "In joining our executive team, Simon will bring valuable experience and capability to support us in our strategy to grow and diversify GSK's business through organic means and bolt-on acquisitions. He will also be responsible for delivering cost savings from our global restructuring programme and implementing further measures to simplify our operational model. I am delighted that someone of his calibre will be joining GSK."

Latest intelligence

The importance of accelerating clinical trial diversity

Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...

Digital Opinion Leaders: The Role of Influencers in Medical Communications

There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...

Creating Hope Though Action – World Suicide Prevention Day

At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....